Background: Lymphoedema represents the cardinal manifestation of lymphatic dysfunction and is associated with expansion of the adipose tissue in the affected limb. In mice, high-fat diet (HFD)-induced obesity was associated with impaired collecting lymphatic vessel function, and adiposity aggravated surgery-induced lymphoedema in a mouse model. The aim of the current study was to investigate whether adiposity is necessary to impair lymphatic function or whether increased lipid exposure alone might be sufficient in a surgical lymphoedema model. Methods: To investigate the role of increased lipid exposure in lymphoedema development we used a well-established mouse tail lymphoedema model. Female mice were subjected to a short-term (6 weeks) HFD, without development of obesity, before surgical induction of lymphedema. Lymphoedema was followed over a period of 6 weeks measuring oedema, evaluating tissue histology and lymphatic vascular function. Results: HFD increased baseline angiogenesis and average lymphatic vessel size in comparison to the chow control group. Upon induction of lymphedema, HFD-treated mice did not exhibit aggravated oedema and no morphological differences were observed in the blood and lymphatic vasculature. Importantly, the levels of fibro-adipose tissue deposition were comparable between the 2 groups and lymphatic vessel function was not impaired as a result of the HFD. Although the net immune cell infiltration was comparable, the HFD group displayed an increased infiltration of macrophages, which exhibited an M2 polarization phenotype. Conclusions: These results indicate that increased adiposity rather than dietary influences determines predisposition to or severity of lymphedema.

1.
Cueni L, Detmar M: The lymphatic system in health and disease. Lymphat Res Biol 2008;6:109-122.
2.
Aspelund A, Robciuc MR, Karaman S, Makinen T, Alitalo K: Lymphatic system in cardiovascular medicine. Circ Res 2016;118:515-530.
3.
Rockson SG: Lymphedema. Am J Med 2001;110:288-295.
4.
Brorson H, Ohlin K, Olsson G, Karlsson MK: Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol 2009;7:3-10.
5.
Zampell JC, Aschen S, Weitman ES, Yan A, Elhadad S, et al: Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg 2012;129:825-834.
6.
Ugur S, Arici C, Yaprak M, Mesci A, Arici GA, et al: Risk factors of breast cancer-related lymphedema. Lymphat Res Biol 2013;11:72-75.
7.
Helyer LK, Varnic M, Le LW, Leong W, McCready D: Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2010;16:48-54.
8.
Greene AK, Grant FD, Slavin SA: Lower-extremity lymphedema and elevated body-mass index. N Engl J Med 2012;366:2136-2137.
9.
Greene AK, Grant FD, Slavin SA, Maclellan RA: Obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg 2015;135:1715-1719.
10.
Arngrim N, Simonsen L, Holst JJ, Bulow J: Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int J Obes (Lond) 2013;37:748-750.
11.
Oliver G: Lymphatic vasculature development. Nat Rev Immunol 2004;4:35-45.
12.
Brorson H: Adipose tissue in lymphedema: the ignorance of adipose tissue in lymphedema. Lymphology 2004;37:175-177.
13.
Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, et al: Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 2005;37:1072-1081.
14.
Escobedo N, Proulx ST, Karaman S, Dillard ME, Johnson N, et al: Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice. JCI Insight 2016:1:e85096.
15.
Blum KS, Karaman S, Proulx ST, Ochsenbein AM, Luciani P, et al: Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS One 2014;9:e94713.
16.
Weitman ES, Aschen SZ, Farias-Eisner G, Albano N, Cuzzone DA, et al: Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One 2013;8:e70703.
17.
Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, et al: Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 2008;16:1261-1269.
18.
Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, et al: Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol 2009;175:1328-1337.
19.
Vuorio T, Nurmi H, Moulton K, Kurkipuro J, Robciuc MR, et al: Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis. Arterioscler Thromb Vasc Biol 2014;34:1162-1170.
20.
Clavin NW, Avraham T, Fernandez J, Daluvoy SV, Soares MA, et al: TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 2008;295:H2113-H2127.
21.
Gousopoulos E, Proulx ST, Scholl J, Uecker M, Detmar M: Prominent lymphatic vessel hyperplasia with progressive dysfunction and distinct immune cell infiltration in lymphedema. Am J Pathol 2016;186:2193-2203.
22.
Proulx ST, Luciani P, Christiansen A, Karaman S, Blum KS, et al: Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis. Biomaterials 2013;34:5128-5137.
23.
Chong C, Scholkmann F, Bachmann SB, Luciani P, Leroux JC, et al: In vivo visualization and quantification of collecting lymphatic vessel contractility using near-infrared imaging. Sci Rep 2016;6:22930.
24.
Silvennoinen M, Rinnankoski-Tuikka R, Vuento M, Hulmi JJ, Torvinen S, et al: High-fat feeding induces angiogenesis in skeletal muscle and activates angiogenic pathways in capillaries. Angiogenesis 2013;16:297-307.
25.
Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA: Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006;72:161-171.
26.
Nores GD, Cuzzone DA, Albano NJ, Hespe GE, Kataru RP, et al: Obesity but not high-fat diet impairs lymphatic function. Int J Obes (Lond) 2016;40:1582-1590.
27.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
28.
Biswas SK, Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11:889-896.
29.
Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, et al: Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2014;17:109-118.
30.
Lamagna C, Aurrand-Lions M, Imhof BA: Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 2006;80:705-713.
31.
Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al: Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009;58:2574-2582.
32.
Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, et al: Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005;115:2192-2201.
33.
Huang SC, Everts B, Ivanova Y, O'Sullivan D, Nascimento M, et al: Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 2014;15:846-855.
34.
Cromer WE, Zawieja SD, Tharakan B, Childs EW, Newell MK, et al: The effects of inflammatory cytokines on lymphatic endothelial barrier function. Angiogenesis 2014;17:395-406.
35.
Scallan JP, Hill MA, Davis MJ: Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling. Cardiovasc Res 2015;107:89-97.
36.
Scallan JP, Davis MJ: Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels. J Physiol 2013;591:2139-2156.
37.
Zawieja SD, Wang W, Wu X, Nepiyushchikh ZV, Zawieja DC, et al: Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. Am J Physiol Heart Circ Physiol 2012;302:H643-H653.
38.
Shaw C, Mortimer P, Judd PA: A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 2007;110:1868-1874.
39.
Shaw C, Mortimer P, Judd PA: Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer 2007;109:1949-1956.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.